Aehr Test Systems

Aehr Test Systems reported a strong Q4 FY2026, beating both revenue and EPS estimates. The company's financial performance and forward guidance indicate a significant turnaround and a promising outlook for FY2027, driven by a record backlog and strong demand from key markets.

Aehr Test Systems reported Q4 FY2026. EPS came in at $0.11 against a -$0.01 consensus, far above expectations. Revenue was $18.8M versus $18.7M expected, beat by 0.6%. Gross margin was 42.6%, up 990 bps from last quarter.

Aehr Test Systems reported a revenue miss and an EPS beat for Q3 FY2026, with revenue of $10.3 million and a non-GAAP EPS of -$0.05. Despite the revenue shortfall, the company's strong backlog and significant bookings indicate a positive outlook for the remainder of the fiscal year.

Aehr Test Systems missed revenue by -14.5%, but the print’s variant signal is not the $9.9 million quarter, it is management putting a $60 million to $80 million bookings marker on the second half while reported backlog was only $11.8 million at quarter-end. The market was priced for a weak near-term revenue base and got one, but it may be underpricing the operating leverage if the order cadence turns the second-half revenue guide into a bridge rather than a ceiling.

Aehr Test Systems printed close to Street revenue and EPS, but the actionable read is that investors were priced for an AI-adjacent recovery while the quarter exposed a consumables and silicon-carbide air pocket. The variant view is that the stock should not be judged on the $11.0 million print alone: the risk is that backlog and customer language support a second-half recovery, but the margin structure will not re-rate until contactor revenue returns from the $2.6 million trough.